Market Tracker

04/17 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

During the Trading Day
19.44 +0.16 / +0.83%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
19.44 0.00 / 0.00%
 
Volume: 5.7K

Today’s Trading

Previous close19.28
Today’s open19.11
Day’s range18.39 - 19.97
Volume2,154,196
Average volume (3 months)2,224,977
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-15.79%
Earnings growth (this year)-25.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-76.67%
P/E ratioNM
Price/Sales1,870.76
Price/Book10.02

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc+0.10+0.44%
CLVSClovis Oncology Inc-1.37-2.44%
RAREUltragenyx Pharmaceu...-2.67-5.90%
IPXLImpax Laboratories I...-0.39-1.60%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 6, 2014
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$1.1M
Annual profit (last year)-$37.9M
Net profit margin-3,314.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Uli Hacksell
Treasurer, Chief Financial &
Business Officer
Thomas H. Aasen
Corporate headquarters
San Diego, California

Forecasts